Lv5
860 积分 2024-07-29 加入
Tumor burden affects the progression pattern on the prognosis in patients treated with sorafenib
1个月前
已完结
The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT
1个月前
已完结
Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis
1个月前
已完结
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab
1个月前
已完结
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma
1个月前
已完结
Sorafenib in Advanced Hepatocellular Carcinoma
1个月前
已完结
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
1个月前
已完结
Can generative artificial intelligence empower target trial emulations?
5个月前
已完结
Methodologies for the Emulation of Biomarker-Guided Trials Using Observational Data: A Systematic Review
7个月前
已完结
皖公网安备34019202002308
